Market Research Industry Reports

Tinea pedis (Athlete Foot) - Pipeline Review, H1 2018

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Tinea pedis (Athlete Foot) - Pipeline Review, H1 2018

Summary

Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Tinea pedis (Athlete Foot) - Pipeline Review, H1 2018, provides an overview of the Tinea pedis (Athlete Foot) (Infectious Disease) pipeline landscape.

Athletes foot, also known as Tinea pedis, is a common foot infection caused by fungi called dermatophytes. Symptoms include dry flaking skin on the soles of the feet, unpleasant foot odour and small itchy bubbles or blisters on the soles of the feet. Treatment includes antifungal medicines.

Report Highlights

Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Tinea pedis (Athlete Foot) - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Tinea pedis (Athlete Foot) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Tinea pedis (Athlete Foot) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tinea pedis (Athlete Foot) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase II, Phase I and Preclinical stages are 1, 3, 2 and 1 respectively.

Tinea pedis (Athlete Foot) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Tinea pedis (Athlete Foot) (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Tinea pedis (Athlete Foot) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Tinea pedis (Athlete Foot) (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Tinea pedis (Athlete Foot) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Tinea pedis (Athlete Foot) (Infectious Disease)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Tinea pedis (Athlete Foot) (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Tinea pedis (Athlete Foot) (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Tinea pedis (Athlete Foot) - Overview
Tinea pedis (Athlete Foot) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Tinea pedis (Athlete Foot) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Tinea pedis (Athlete Foot) - Companies Involved in Therapeutics Development
Astellas Pharma Inc
Biolab Farmaceutica Ltda
Blueberry Therapeutics Ltd
Novan Inc
Tinea pedis (Athlete Foot) - Drug Profiles
AS-2077715 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dapaconazole - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
nitric oxide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
nitric oxide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NORS-6491 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
terbinafine hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
terbinafine hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Tinea pedis (Athlete Foot) - Dormant Projects
Tinea pedis (Athlete Foot) - Product Development Milestones
Featured News & Press Releases
May 17, 2018: SB208 Increases Daily Nail Growth Rate over Four Weeks of Treatment
Jan 11, 2018: Novan to Present Positive Phase 2 Results for SB208 Antifungal Program at Winter Clinical Dermatology Conference
Apr 12, 2017: Novan Reports Positive Topline Results with SB208 in Phase 2 Trial
Jul 21, 2016: Novan Announces First Patient Dosed in Phase 2 Anti-Fungal Program
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List Of Tables

List of Tables
Number of Products under Development for Tinea pedis (Athlete Foot), H1 2018
Number of Products under Development by Companies, H1 2018
Products under Development by Companies, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Tinea pedis (Athlete Foot) - Pipeline by Astellas Pharma Inc, H1 2018
Tinea pedis (Athlete Foot) - Pipeline by Biolab Farmaceutica Ltda, H1 2018
Tinea pedis (Athlete Foot) - Pipeline by Blueberry Therapeutics Ltd, H1 2018
Tinea pedis (Athlete Foot) - Pipeline by Novan Inc, H1 2018
Tinea pedis (Athlete Foot) - Dormant Projects, H1 2018

List Of Figures

List of Figures
Number of Products under Development for Tinea pedis (Athlete Foot), H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products by Targets, H1 2018
Number of Products by Stage and Targets, H1 2018
Number of Products by Mechanism of Actions, H1 2018
Number of Products by Stage and Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Stage and Molecule Types, H1 2018

Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2018

Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2018The latest Pharmaceutical and Healthcare disease pipeline guide Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2018, provides an overview of the Onychomycosis (Tinea

USD 2000View Report

Tinea pedis (Athlete Foot) - Pipeline Review, H1 2018

Tinea pedis (Athlete Foot) - Pipeline Review, H1 2018Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Tinea pedis (Athlete Foot) - Pipeline Review, H1 2018, provides an overview

USD 2000View Report

Athletes Foot (Tinea Pedis) - Market Insight, Epidemiology and Market Forecast - 2027

DelveInsights Athletes Foot (Tinea Pedis) - Market Insight, Epidemiology and Market Forecast - 2027 report provides a detailed analysis of the Athletes Foot (Tinea Pedis) epidemiology and market

USD 6250View Report

Athletes Foot (Tinea Pedis) - Epidemiology Forecast to 2027

DelveInsights Athletes Foot (Tinea Pedis) - Epidemiology Forecast, 2027 report provides a comprehensive analysis of the Athletes Foot (Tinea Pedis) epidemiology, providing the historical and forecasted

USD 3250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 2000
  • Site Licence    USD 4000
  • Enterprise Wide Licence    USD 6000
$ 2000

Reports Details

Published Date : Jun 2018
No. of Pages :35
Country :Global
Category :Pharmaceuticals and Healthcare
Publisher :Global Markets Direct
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube